FDA Inspection 1260553 — Nathalie Daaboul
The FDA completed an inspection of Nathalie Daaboul on Jan 24, 2025 in Greenfield Park. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 24, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Greenfield Park (Canada)
Additional Details
Clinical Investigator (CI)